May 15, 2024 —Cardio Focus Co., Ltd.is a medical device company focused on advancing ablative treatments for cardiac arrhythmias. heart rhythm 2024 The conference will be held in person and virtually at the Boston Convention & Exhibition Center from May 16-19, 2024.
CardioFocus features a portfolio of innovative ablation systems that optimize lesion formation with confirmed tissue contact and advanced energy delivery. This includes the basic HeartLite X3, the next generation ultra-compliant PFA balloon for true single-shot pulmonary vein isolation, and the recently acquired Centauri™ pulsed electric field system and QuickShot™ large-area focused PFA catheter. Using a new proprietary waveform, Centauri is compatible with several commercially available focal ablation catheters and mapping systems.
“Our pursuit of innovation toward clinically meaningful ablation systems is driven by a focus on patient outcomes,” said Steve Ogilvie, CEO of CardioFocus. “At Heart Rhythm 2024, we will announce new data and products demonstrating our ability to customize unique pulse field waveforms in each catheter system to deliver precise energy for safe and durable lesion formation.” To do.”
CardioFocus will present new clinical data in two abstract sessions and a rhythm theater presentation titled “Shaping the Future of Cardiac Ablation: How Contact and Waveform Science Enhance PFA Lesion Durability.”
Data-driven pulse field summary
Shefalu K. Doshi, M.D., FACC, Pacific Heart Institute, Santa Monica, Calif., and Keita Watanabe, M.D., Mount Sinai Hospital, New York, N.Y., present Centauri and its companion QuickShot catheter, as well as CardioFocus pulsed-field ablation.・We will present data that supports the balloon. True single pulmonary vein isolation methods are currently under development.
- PO-02-108 – Pulsed-field ablation of atrial fibrillation using a large-area focusing catheter with a novel contact detection algorithm – Invasive remapping results for the QuickShot catheter and CENTAURI system – Poster Session II – Ablation – May 17 Friday, 1:00pm – 3:00pm EDT – Abstract Pavilion
- PO-06-144 – Initial Demonstration of Multielectrode Endoscopic Balloon Pulsed Field Ablation Catheter: Early Preclinical Feasibility – Poster Session VI – Ablation – Sunday, May 19th, 9:30 a.m. – 11:30 a.m. Minutes EDT – Abstract Pavilion
Rhythm Theater Presentation on Pulsed Field Lesion Durability
Dr. Shefaal K. Doshi will moderate the Rhythm Theater presentation titled “Shaping the Future of Cardiac Ablation: How Contact and Waveform Science Enhances PFA Lesion Durability.” Presentations were by Hiroshi Nakagawa, MD, PhD, of the Cleveland Clinic, Cleveland, OH; David Kenigsberg, MD, FHRS, FACC, Westside Regional Medical Center, Plantation, FL; Jacob Corse, MD, Mount Sinai Hospital, NY; Made by New York. , and Dr. Jim Hansen, DMSc, Gentofte Hospital, Hellerup, Denmark, May 18, 2024, 10:30 a.m. – 11:30 a.m. EDT, Rhythm Theater #2.
Exhibition hall booths and tech suites
CardioFocus' home base at Heart Rhythm 2024 will be at booth 653, where the company will release new visual branding that captures the fundamentals and future of CardioFocus and combines elements of both in a modern design. At our booth, we will be showcasing the HeartLight X3 and Centauri PFA system. CardioFocus will also play host to two tech suites (TS254 and TS256) to share products the company is currently developing, including his navigation-enabled QuickShot and true Single Shot ultra-compliant PFA balloons.
Abstracts will be published on May 16, 2024. Once published, abstracts and presentations can be accessed at: https://heartrhythm.com/.
Click here for detailed coverage of the HRS24 conference